EU Investigation Confirms No Link Between Weight Loss and Diabetes Drugs and Suicidal Thoughts
Friday, 12 April 2024, 13:27
EU Investigation on Weight Loss and Diabetes Drugs
The recent review conducted by the EU focused on various drugs, including Wegovy, Ozempic, Rybelsus, and Saxenda, developed by Novo Nordisk. The investigation aimed to determine if there was any correlation between these medications and suicidal thoughts.
Findings and Exclusions
- No Link Found: The EU investigation concluded that there is no connection between the examined drugs and suicidal thoughts, providing relief for patients.
- Excluded Drugs: Notably, Eli Lilly's Zepbound and Mounjaro were not part of this review.
This outcome offers important insights into the safety of these medications and brings clarity to patients and healthcare providers.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.